Infrastructure
Milestone Alert: VRG Tx Launches Its In Vivo R&D Facility!

We are thrilled to announce the launch of our state-of-the-art animal in vivo facility, a crucial expansion to our existing in silico and in vitro capabilities.

This new addition enables VRG Tx to seamlessly integrate the full spectrum of drug discovery—from in silico de novo design, through in vitro optimization, to animal in vivo characterization.

With this new facility dedicated to animal studies, we're poised to accelerate our research and deliver solutions that meet real-world health challenges faster than ever.

Join us on this journey and be part of our success story!

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
April 11, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
April 11, 2024
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Combi-X
VRG-145
April 17, 2024
By VRG Therapeutics
VRG Therapeutics Advances VRG-145
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
March 12, 2024
By VRG Therapeutics
Journal of Biological Chemistry
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Combi-X
VRG-145
April 17, 2024
By VRG Therapeutics
VRG Therapeutics Advances VRG-145
White arrow icon up and right direction redirecting to Partner with US page
Kv1.3
March 12, 2024
By VRG Therapeutics
Journal of Biological Chemistry
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life